This is the authors' abstract. We don't add key points for this paper.
Herein, we construct a series of Ru(II) metallacycles with multimodal chemo-phototherapeutic properties, which exhibited much higher anticancer activity and better cancer-cell selectivity than cisplatin. The antitumor mechanism could be ascribed to the activation of caspase 3/7 and the resulting apoptosis. These results open new possibilities for Ru(II) metallacycles in biomedicine.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: